Like with many other pharma giants, AbbVie’s manufacturing expansion will see the company put down roots in North Carolina. More: AbbVie to establish NC production base with .4B investment, creating 730-plus jobs Source: fierce
read moreThe Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers. More: CMS delays Part D GLP-1 model amid skepticism from insurers Source: fierce
read moreThe industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained the motivation for his company’s $1.1 billion acquisition of Kashiv BioSciences. More: Amneal seizes 'golden era' for biosims with .1B Kashiv
read moreAs Samsung Biologics presented a massive quarterly revenue growth, 2,200 people rallied ahead of a planned labor union strike. More: Samsung Biologics posts massive revenue growth as labor union rally sets strike in motion Source: fierce
read moreAmid industry layoffs and M&A headlines, Big Pharma’s embrace of AI is gaining more steam. More: Merck goes with Google for AI push, striking enterprise partnership worth up to B Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals